Tyrosinemia type 3
Other Names for this Disease
- 4-alpha hydroxyphenylpyruvate dioxygenase deficiency
- 4-alpha hydroxyphenylpyruvic acid oxidase deficiency
- 4-hydroxyphenylpyruvate dioxygenase deficiency
- Tyrosinemia type III
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
HPD gene. Characteristic features include intellectual disability, seizures, and periodic loss of balance and coordination (intermittent ataxia). Tyrosinemia type 3 is inherited in an autosomal recessive manner.Tyrosinemia type 3 is a genetic disorder characterized by elevated blood levels of the amino acid tyrosine, a building block of most proteins. This condition is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase, one of the enzymes required for the multi-step process that breaks down tyrosine. This enzyme shortage is caused by mutations in the
Last updated: 2/3/2010
- Tyrosinemia. Genetics Home Reference (GHR). 2008; http://ghr.nlm.nih.gov/condition=tyrosinemia. Accessed 2/3/2010.
- Genetics Home Reference (GHR) contains information on Tyrosinemia type 3. This website is maintained by the National Library of Medicine.
- Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
- Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.
- Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
- PubMed is a searchable database of medical literature and lists journal articles that discuss Tyrosinemia type 3. Click on the link to view a sample search on this topic.